SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ:SQNM), a leading provider of fine mapping genotyping, methylation and gene expression analysis solutions, today announced the sales of multiple MassARRAY® systems in China. Sequenom’s new MassARRAY customers include the Beijing Genomics Institute (BGI), Asia’s largest genetic sequencing center, which plans to initially use the system for its advanced research in viral genetics and later for human genetic projects, and CapitalBio, a leading China-based life science service company with capacities for whole genome association studies, which plans to expand into the fine mapping market.
